Allopregnanolone Agonists for Depression: Brexanolone & Zuranolone in Focus
Depression affects over 300 million people globally. Current treatments have limited efficacy for many patients. Exciting new research highlights the potential of allopregnanolone agonists like brexanolone and zuranolone as more targeted, rapid-acting antidepr…
Read article